Successful Control of Disseminated Scedosporium prolificans Infection with a Combination of Voriconazole and Terbinafine

@article{Howden2003SuccessfulCO,
  title={Successful Control of Disseminated Scedosporium prolificans Infection with a Combination of Voriconazole and Terbinafine},
  author={B. Howden and M. Slavin and A. Schwarer and A. Mijch},
  journal={European Journal of Clinical Microbiology and Infectious Diseases},
  year={2003},
  volume={22},
  pages={111-113}
}
  • B. Howden, M. Slavin, +1 author A. Mijch
  • Published 2003
  • Medicine
  • European Journal of Clinical Microbiology and Infectious Diseases
  • Disseminated Scedosporium prolificans infections are almost uniformly fatal because of their resistance to antifungal agents. Recently, synergy between triazoles and terbinafine has been demonstrated against Scedosporium prolificans in vitro. Reported here is a patient who developed disseminated Scedosporium prolificans infection following bone marrow transplantation and who was successfully treated with a combination of voriconazole and terbinafine in addition to aggressive surgical… CONTINUE READING
    169 Citations
    Successful control of Scedosporium prolificans septic arthritis and probable osteomyelitis without radical surgery in a long‐term renal transplant recipient
    • 39

    References

    SHOWING 1-10 OF 13 REFERENCES
    Disseminated infection and colonization by Scedosporium prolificans: a review of 18 cases, 1990-1999.
    • 108
    • PDF
    Disseminated infection by Scedosporium Prolificans: an emerging fatality among haematology patients. Case report and review
    • 80
    In Vitro Interaction of Terbinafine with Itraconazole against Clinical Isolates of Scedosporium prolificans
    • 88
    • PDF
    Airborne outbreak of nosocomial Scedosporium prolificans infection
    • 39
    Disseminated phaeohyphomycosis: review of an emerging mycosis.
    • 330
    • PDF
    Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species.
    • 107
    • PDF
    In Vitro Activities of New and Conventional Antifungal Agents against Clinical Scedosporium Isolates
    • 211
    • PDF
    National Committee for Clinical Laboratory Standards.
    • 12,127